nach oben

Erschienen in:

05.07.2022 | Original Article

A retrospective 5-year survival analysis of surgically resected gastric cancer cases from the Japanese Gastric Cancer Association nationwide registry (2001–2013)

verfasst von: Yoshihiro Kakeji, Takashi Ishikawa, Satoshi Suzuki, Kohei Akazawa, Tomoyuki Irino, Isao Miyashiro, Hiroyuki Ono, Haruhisa Suzuki, Satoshi Tanabe, Shigenori Kadowaki, Kei Muro, Takeo Fukagawa, Souya Nunobe, Takeyuki Wada, Hitoshi Katai, Yasuhiro Kodera, Registration Committee of the Japanese Gastric Cancer Association

Erschienen in: Gastric Cancer | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

The nationwide registry of the Japanese Gastric Cancer Association collected data of surgically resected cases of gastric cancer between 2001 and 2013. These retrospective analyses aimed to delineate tumor characteristics, surgical history, and survival distribution.

Methods

Data from 254,706 patients with primary gastric cancer were included. The 5-year survival rates were calculated for various subsets of prognostic factors.

Results

The number of patients over 70 years old increased from 2001 to 2013. The frequency with which laparoscopic gastrectomy was opted for increased dramatically (from 3.5 to 40.8%) in 13 years. We focused on the patients registered between 2010 and 2013, for whom data collection was based on the 3rd edition of the Japanese classification and guidelines. Five-year overall survival (OS) rate among 92,305 patients with resected tumors was 70.6%. The 5-year OS rates of patients with pathological stage IA, IB, IIA, IIB, IIIA, IIIB, IIIC, and IV disease were 89.6%, 83.2%, 77.6%, 68.1%, 59.3%, 45.6%, 29.9%, and 14.0%, respectively.

Conclusion

Our detailed analysis highlights the historical changes in outcomes of surgically treated gastric malignancies in Japan, and provides robust dataset for future analysis.

Nur mit Berechtigung zugänglich

Japanese Research Society for Gastric Cancer, Japanese Gastric Cancer Association. Zenkoku igan touroku chousa houkokusyo (Statistical report of nationwide registry of gastric carcinoma), no. 1–54. Tokyo: National Cancer Center; 1972–2001.

Isobe Y, Nashimoto A, Akazawa K, Oda I, Hayashi K, Miyashiro I, et al. Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer. 2011;14(4):301–16.CrossRef

Nashimoto A, Akazawa K, Isobe Y, Miyashiro I, Katai H, Kodera Y, et al. Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry. Gastric Cancer. 2013;16:1–27.CrossRef

Katai H, Ishikawa T, Akazawa K, Isobe Y, Miyashiro I, Oda I, et al. Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001–2007). Gastric Cancer. 2018;21:144–54.CrossRef

Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14(2):101–12.CrossRef

Japanese Gastric Cancer Association. Japanese Gastric Cancer Treatment Guidelines 2010 (ver. 3). Gastric Cancer. 2011;14(2):113–23.CrossRef

Sano T, Aiko T. New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points. Gastric Cancer. 2011;14:97–100.CrossRef

International Union Against Cancer. In: Sobin LH, Gospodarowicz MK, Wittekind C, editors. TNM classification of malignant tumours. 7th ed. New Jersey: Wiley-Blackwell; 2009.

http://www.jgca.jp/entry/iganhtml/download.html.

10.

Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma—2nd English edition. Gastric Cancer. 1998;1:10–24.CrossRef

11.

Sobin LH, Wittekind C, editors. TNM classification of malignant tumors. 5th ed. New York: Wiley-Liss; 1997.

12.

Cancer Information Service, National Cancer Center, Japan. Cancer Incidence (1975–2015) Table download. https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fganjoho.jp%2Freg_stat%2Fstatistics%2Fdata%2Fdl%2Fexcel%2Fcancer_incidence(1975-2015).xls&wdOrigin=BROWSELINK.

13.

Marubashi S, Takahashi A, Kakeji Y, Hasegawa H, Ueno H, Eguchi S, et al. Surgical outcomes in gastroenterological surgery in Japan: report of the National Clinical Database 2011–2019. Ann Gastroenterol Surg. 2021;5(5):639–58.CrossRef

14.

Ono H, Yao K, Fujishiro M, Oda I, Uedo N, Nimura S, et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition). Dig Endosc. 2021;33(1):4–20.CrossRef

15.

Ono H. The history, present status and future perspective of ESD for GI tract cancer. Nihon Shokakibyo Gakkai Zasshi. 2017;114:971–7 (Japanese).PubMed

16.

Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357(18):1810–20.CrossRef

17.

Suzuki S, Takahashi A, Ishikawa T, Akazawa K, Katai H, Isobe Y, et al. Surgically treated gastric cancer in Japan: 2011 annual report of the national clinical database gastric cancer registry. Gastric Cancer. 2021;24(3):545–66.CrossRef

Titel: A retrospective 5-year survival analysis of surgically resected gastric cancer cases from the Japanese Gastric Cancer Association nationwide registry (2001–2013)
verfasst von: Yoshihiro Kakeji
Takashi Ishikawa
Satoshi Suzuki
Kohei Akazawa
Tomoyuki Irino
Isao Miyashiro
Hiroyuki Ono
Haruhisa Suzuki
Satoshi Tanabe
Shigenori Kadowaki
Kei Muro
Takeo Fukagawa
Souya Nunobe
Takeyuki Wada
Hitoshi Katai
Yasuhiro Kodera
Registration Committee of the Japanese Gastric Cancer Association
Publikationsdatum: 05.07.2022
Verlag: Springer Nature Singapore
Erschienen in: Gastric Cancer / Ausgabe 6/2022
Print ISSN: 1436-3291
Elektronische ISSN: 1436-3305
DOI: https://doi.org/10.1007/s10120-022-01317-6

Heterogeneity and evolution of tumour immune microenvironment in metastatic gastroesophageal adenocarcinoma

Open Access
Original Article

The feasibility and safety of endoscopic submucosal dissection of gastric lesions larger than 5 cm

Original Article

Development of the PERI-Gastric (PEritoneal Recurrence Index) and PERI-Gram (Peritoneal Recurrence Index NomoGRAM) for predicting the risk of metachronous peritoneal carcinomatosis after gastrectomy with curative intent for gastric cancer: a methodology issue

Letter to the Editor

PD-L1 IHC testing: issues with interchangeability evidence based on laboratory-developed assays of unknown analytical performance

Letter to the Editor

Impact of body composition on survival of PD-1/PD-L1-treated metastatic gastro-esophageal junction/gastric cancer

Letter to the Editor

Open versus laparoscopic gastrectomy for advanced gastric cancer: a propensity score matching analysis of survival in a western population—on behalf of the Italian Research Group for Gastric Cancer

Original Article

Neu im Fachgebiet Chirurgie

Akute Cholezystitis bei multimorbiden Älteren: Operation nicht sofort ausschließen!

16.04.2025
Operationen an Gallenblase und Gallenwegen
Nachrichten

Bei älteren, multimorbiden Menschen mit akuter Cholezystitis wird eine Operation häufig nicht erwogen. Eine Studie aus Philadelphia zeigt nun jedoch, dass auch diese Patientinnen und Patienten von einer chirurgischen Therapie profitieren können.

Was geschehen muss, damit Prähabilitation in die Leitlinien kommt

08.04.2025
DCK 2025
Nachrichten

Eine Prähabilitation vor einem viszeralchirurgischen Eingriff ist Experten zufolge äußerst sinnvoll, dennoch wird sie in Leitlinien derzeit nicht empfohlen. Beim DCK erklärte Prof. Tim Vilz aus Bonn, woran das liegt und was benötigt wird, um die Situation zu ändern.

Thoracic-Outlet-Syndrom nur in Ausnahmefällen operieren!

08.04.2025
DCK 2025
Nachrichten

Das Thoracic-Outlet-Syndrom erfordert nur in ganz bestimmten Fällen ein operatives Vorgehen. Beim DCK wurde vor schwerwiegenden Komplikationen des anspruchsvollen Eingriffs gewarnt.

Statine: Was der G-BA-Beschluss für Praxen bedeutet

06.04.2025
Praxis und Beruf
Nachrichten

Nach dem G-BA-Beschluss zur erweiterten Verordnungsfähigkeit von Lipidsenkern rechnet die DEGAM mit 200 bis 300 neuen Dauerpatienten pro Praxis. Im Interview erläutert Präsidiumsmitglied Erika Baum, wie Hausärztinnen und Hausärzte am besten vorgehen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

A retrospective 5-year survival analysis of surgically resected gastric cancer cases from the Japanese Gastric Cancer Association nationwide registry (2001–2013)